Protein Consumption in Critically Ill Patients
1 other identifier
observational
2,000
1 country
3
Brief Summary
A retrospective study of protein intake and needs as well as outcomes in critically ill adult patients. Data will be collected for up to 7 days of ICU stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2016
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 4, 2016
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedNovember 6, 2018
November 1, 2018
1.2 years
October 4, 2016
November 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Daily protein intake (from Parenteral Nutrition, Enteral Nutrition, oral diet, and medication)
Daily up to 7 days of ICU stay
Secondary Outcomes (29)
Enteral formula utilized (Standard, High protein, Very high protein)
Daily up to 7 days of ICU stay
Daily caloric intake (from Parenteral Nutrition, Enteral Nutrition, oral diet, and medication)
Daily up to 7 days of ICU stay
Estimated caloric needs (Kcal/day)
Daily up to 7 days of ICU stay
Method for estimating caloric needs (descriptive name of scale) calorie needs met.
Daily up to 7 days of ICU stay
Percentage of daily caloric needs met (%) calorie needs met.
Daily up to 7 days of ICU stay
- +24 more secondary outcomes
Eligibility Criteria
The study population will include all patients with an ICU admission receiving enteral nutrition in a 36-month period.
You may qualify if:
- Adult patients (age ≥18 years)
- Admitted to the ICU
- Administered at least one dose of enteral formula
You may not qualify if:
- Receiving exclusive oral or exclusive parenteral nutrition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Société des Produits Nestlé (SPN)lead
- Geisinger Cliniccollaborator
Study Sites (3)
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
Geisinger Community Medical Center, Scranton, PA
Scranton, Pennsylvania, 18510, United States
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, 18711, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Layon, MD, FACP
Geisinger Clinic
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2016
First Posted
February 9, 2017
Study Start
September 1, 2016
Primary Completion
December 1, 2017
Study Completion
September 1, 2018
Last Updated
November 6, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share